EUVIMEDEUVIMED entdecken
Crossref

Novel antimicrobial peptide HFIAP-1 mutant as a β-lactamase inhibitor against extended-spectrum β-lactamases of Escherichia coli: a comprehensive in-silico approach

Elizabeth Annie George iD, Aniket Naha iD, Sudha Ramaiah

Archives of Microbiology · 2025

DOI: 10.1007/s00203-025-04483-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, 2025. Verfasst von Elizabeth Annie George und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio-Sciences, School of Bio-Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, 632014, India. Hauptthemen laut MEDLINE: Escherichia coli, beta-Lactamase Inhibitors, beta-Lactamases, Anti-Bacterial Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia colibeta-Lactamase Inhibitorsbeta-LactamasesAnti-Bacterial AgentsAntimicrobial PeptidesEscherichia coli ProteinsAntimicrobial Cationic PeptidesMolecular Docking SimulationMicrobial Sensitivity TestsComputer SimulationMutationMolecular Dynamics Simulation

Stichwörter der Autor:innen

Antimicrobial peptidesExtended spectrum β-lactamasesIntermolecular interactionsMolecular dockingMolecular dynamics simulation

Substanzen

beta-Lactamase Inhibitorsbeta-LactamasesAnti-Bacterial AgentsAntimicrobial PeptidesEscherichia coli ProteinsAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Department of Bio-Sciences, School of Bio-Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, 632014, India.
  • Medical and Biological Computing Laboratory, School of Bio-Sciences and Technology (SBST), Vellore Institute of Technology, Vellore, 632014, India.
  • Medical Biotechnology and Computational Drug Designing Laboratory, Pushpagiri Institute of Medical Sciences and Research Centre, Pushpagiri Medical Society, Tiruvalla, Kerala, 689101, India.
  • Department of Bio-Sciences, School of Bio-Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, 632014, India. sudhaanand@vit.ac.in.
  • Medical and Biological Computing Laboratory, School of Bio-Sciences and Technology (SBST), Vellore Institute of Technology, Vellore, 632014, India. sudhaanand@vit.ac.in.

ORCID-Profile: Elizabeth Annie George, Aniket Naha

Förderung

  • Indian Council of Medical Research

Zitieren

APA

George, E. A., Naha, A., & Ramaiah, S. (2025). Novel antimicrobial peptide HFIAP-1 mutant as a β-lactamase inhibitor against extended-spectrum β-lactamases of Escherichia coli: a comprehensive in-silico approach. Archives of Microbiology. https://doi.org/10.1007/s00203-025-04483-0

Vancouver

George EA, Naha A, Ramaiah S. Novel antimicrobial peptide HFIAP-1 mutant as a β-lactamase inhibitor against extended-spectrum β-lactamases of Escherichia coli: a comprehensive in-silico approach. Archives of Microbiology. 2025. doi:10.1007/s00203-025-04483-0

BibTeX
@article{George2025,
  author = {George, Elizabeth Annie and Naha, Aniket and Ramaiah, Sudha},
  title = {Novel antimicrobial peptide HFIAP-1 mutant as a β-lactamase inhibitor against extended-spectrum β-lactamases of Escherichia coli: a comprehensive in-silico approach},
  journal = {Archives of Microbiology},
  year = {2025},
  doi = {10.1007/s00203-025-04483-0}
}
Kostenlos starten →